Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 33342-222

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 33342-222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine-er-tab-14-mg-100-blister-carton.jpg (Memantine Er Tab 14 mg 100 Blister Carton)

Memantine Hydrochloride 14 mg extended release capsules packaging label by Macleods Pharmaceuticals Limited. The label indicates a 100-count package (10 x 10 unit dose) for oral administration, with the dosage strength prominently displayed. It includes manufacturer information, batch and expiration date sections, and dosing instructions stating once daily use.*

FDA Label Image

125 (Memantine Er Tab 14 mg 30s)

Packaging label for Memantine Hydrochloride Extended-Release Capsules 14 mg by Macleods Pharmaceuticals Limited. The label indicates a 30-capsule container with dosing instructions to take once daily. It includes storage instructions, manufacturer details, and an NDC barcode.*

FDA Label Image

Memantine-er-tab-21-mg-100-blister-carton.jpg (Memantine Er Tab 21 mg 100 Blister Carton)

Packaging label for Memantine Hydrochloride Extended Release Capsules 21 mg by Macleods Pharmaceuticals Limited. The label indicates a 100-capsule supply (10 x 10 unit dose) with storage instructions and manufacturer details including Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. The label includes a barcode and space for batch and expiration information.*

FDA Label Image

125 (Memantine Er Tab 21 mg 30s)

Label for Memantine Hydrochloride Extended-Release Capsules, 21 mg strength, oral dosage form. The label indicates a 30 capsule count and notes once daily use. Manufactured by Macleods Pharmaceuticals Limited, with packaging mentioning Macleods Pharma USA, Princeton, NJ. Storage and dosage instructions are partially visible along with barcode and lot code areas.*

FDA Label Image

Memantine-er-tab-28-mg-100-blister-carton.jpg (Memantine Er Tab 28 mg 100 Blister Carton)

Memantine Hydrochloride Extended Release Capsules 28 mg packaging label. The label shows the product name with strength, dosage form, and the quantity of 100 capsules (10 x 10 unit dose). It includes the labeler name Macleods Pharmaceuticals Limited and manufacturing details for Macleods Pharma USA, Inc. The label also states the product is Rx only and designed for once daily oral use.*

FDA Label Image

125 (Memantine Er Tab 28 mg 30s)

Memantine Hydrochloride Extended-Release Capsules 28 mg by Macleods Pharmaceuticals Limited. The label shows Macleods Pharma USA as the distributor, and the package contains 30 capsules. The label includes dosage and storage instructions, barcode, and manufacturing details from Baddi, Himachal Pradesh, India.*

FDA Label Image

Memantine-er-tab-7-mg-100-blister-carton.jpg (Memantine Er Tab 7 mg 100 Blister Carton)

Memantine Hydrochloride Extended Release Capsules 7 mg, oral extended release capsules labeled for once daily use. The label indicates a package containing 100 capsules (10 x 10 Unit dose). Manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA, with storage instructions and dosage information provided on the label along with the NDC 33342-219-12.*

FDA Label Image

125 (Memantine Er Tab 7 mg 30s)

Memantine Hydrochloride Extended-Release Capsules 7 mg, 30 capsules per bottle, by Macleods Pharmaceuticals Limited. Label includes dosage strength, storage instructions, and manufacturing information for the oral extended-release capsule form.*

FDA Label Image

Memantine-er-tab-figure-1.jpg (Memantine Er Tab Figure 1)

Line graph showing mean (± SEM) change from baseline in SIB score over 24 weeks of treatment comparing Memantine hydrochloride extended-release 28 mg (Memantine HCl ER 28 mg/AChEI) and Placebo, both with AChEI. The graph illustrates clinical improvement above zero and clinical decline below zero on the vertical axis, with weeks of treatment on the horizontal axis.*

FDA Label Image

Memantine-er-tab-figure-2.jpg (Memantine Er Tab Figure 2)

A cumulative percentage of patients chart comparing Memantine hydrochloride extended-release 28 mg versus placebo, showing changes in SIB (Severe Impairment Battery) scores from baseline. The x-axis represents SIB change from baseline, while the y-axis shows the cumulative percentage of patients. The chart includes two curves, one for Memantine HCl ER 28 mg and one for placebo, illustrating their respective patient response distributions.*

FDA Label Image

Memantine-er-tab-figure-3.jpg (Memantine Er Tab Figure 3)

A line graph showing mean (± SEM) CIBIC-Plus scores over 24 weeks of treatment comparing Memantine hydrochloride extended release 28 mg with placebo, both combined with AChEI. The x-axis represents weeks of treatment (0 to 24), and the y-axis shows mean CIBIC-Plus scores. Data points indicate clinical improvement and decline trends for each treatment group over time.*

FDA Label Image

Memantine-er-tab-figure-4.jpg (Memantine Er Tab Figure 4)

A bar chart comparing the percentage of patients by CIBIC Plus Rating for Memantine hydrochloride extended release 28 mg and placebo groups. The chart shows ratings ranging from marked improvement to marked worsening, with percentages for each category displayed on the vertical axis and CIBIC Plus ratings on the horizontal axis.*

FDA Label Image

145 (Memantine Er Tab Structure)

Chemical structure diagram of Memantine hydrochloride, showing its molecular framework with labeled functional groups and atoms as typically depicted in pharmaceutical chemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.